Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Root Cause of Thyroid Cancer Epidemic Due to Overdiagnosis

By HospiMedica International staff writers
Posted on 01 Sep 2016
A new study concludes that the growing epidemic of thyroid cancer reported in several high-income countries is largely due to overdiagnosis.

Researchers at the International Agency for Research on Cancer (IARC, Lyon, France) and the Aviano National Cancer Institute (CRO; Italy) used high-quality cancer registry data to estimate the number of overdiagnosed cases of thyroid cancer in 12 countries (Australia, Denmark, England, Finland, France, Italy, Japan, Norway, Republic of Korea, Scotland, Sweden, and the USA). More...
In all, they estimated that more than 470,000 women and 90,000 men may have been overdiagnosed with thyroid cancer during the last two decades.

The estimated fraction of overdiagnosis cases in women was 70-80% in Australia, France, Italy, and the USA, approximately 50% in Japan, the Nordic countries, England, and Scotland, and approximately 90% in South Korea. In men, the incidences reported were similar but less pronounced, with an estimated overdiagnosis of approximately 70% in France, Italy, and the Republic of Korea, 45% in Australia and the USA, and less than 25% in all other countries examined. The study was published on August 18, 2016, in The New England Journal of Medicine.

“Countries such as the USA, Italy, and France have been most severely affected by overdiagnosis of thyroid cancer since the 1980’s, after the introduction of ultrasonography, but the most recent and striking example is the Republic of Korea,” said lead author Salvatore Vaccarella, PhD, of the IARC. “A few years after ultrasonography of the thyroid gland started being widely offered in the framework of a population-based multi-cancer screening, thyroid cancer has become the most commonly diagnosed cancer in women in the Republic of Korea.”

“The drastic increase in overdiagnosis and overtreatment of thyroid cancer is already a serious public health concern in many high-income countries, with worrying signs of the same trend in low- and middle-income countries,” said Christopher Wild, MD, director of the IARC. “It is therefore critical to have more research evidence in order to evaluate the best approach to address the epidemic of thyroid cancer and to avoid unnecessary harm to patients.”

Increasing medical surveillance and new diagnostic techniques, such as neck ultrasonography, computed tomography (CT) scanning, and magnetic resonance imaging (MRI), have led to the detection of a large number of indolent, non-lethal diseases that exist in abundance in the thyroid gland of healthy people of any age. Most of these tumors are very unlikely to cause symptoms or death during the lifetime of the patient.

Related Links:
International Agency for Research on Cancer
Aviano National Cancer Institute

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.